ProstaLund AB
ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally mark… Read more
ProstaLund AB (PLUN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.052x
Based on the latest financial reports, ProstaLund AB (PLUN) has a cash flow conversion efficiency ratio of -0.052x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.31 Million) by net assets (Skr44.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ProstaLund AB - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how ProstaLund AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ProstaLund AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ProstaLund AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
72GU
LSE:72GU
|
N/A |
|
BIJBF
OTCGREY:BIJBF
|
N/A |
|
Transpaco Ltd
JSE:TPC
|
0.044x |
|
CYMBRIA CORP. CLASS A
F:CYOA
|
N/A |
|
THE BITCOIN FUND UTS A
F:7T9
|
N/A |
|
nDatalyze Corp
OTCQB:NDATF
|
-0.075x |
|
ATLANTICUS HLDGS
BE:YCC
|
0.247x |
|
SURFACE TRANSF PLC LS-01
F:XE4
|
N/A |
Annual Cash Flow Conversion Efficiency for ProstaLund AB (2012–2024)
The table below shows the annual cash flow conversion efficiency of ProstaLund AB from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr55.18 Million | Skr-22.59 Million | -0.409x | +4.89% |
| 2023-12-31 | Skr55.29 Million | Skr-23.80 Million | -0.430x | -10.75% |
| 2022-12-31 | Skr41.69 Million | Skr-16.20 Million | -0.389x | -137.43% |
| 2021-12-31 | Skr35.46 Million | Skr-5.80 Million | -0.164x | +51.64% |
| 2020-12-31 | Skr25.35 Million | Skr-8.58 Million | -0.338x | +17.44% |
| 2019-12-31 | Skr22.23 Million | Skr-9.12 Million | -0.410x | +56.18% |
| 2018-12-31 | Skr12.71 Million | Skr-11.89 Million | -0.936x | +20.02% |
| 2017-12-31 | Skr13.78 Million | Skr-16.11 Million | -1.170x | -150.18% |
| 2016-12-31 | Skr30.81 Million | Skr-14.41 Million | -0.468x | -11.23% |
| 2015-12-31 | Skr23.19 Million | Skr-9.75 Million | -0.420x | +53.88% |
| 2014-12-31 | Skr11.89 Million | Skr-10.83 Million | -0.911x | -23.12% |
| 2013-12-31 | Skr5.23 Million | Skr-3.88 Million | -0.740x | -33.32% |
| 2012-12-31 | Skr4.69 Million | Skr-2.60 Million | -0.555x | -- |